Smolen Js

829 total citations
30 papers, 654 citations indexed

About

Smolen Js is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Smolen Js has authored 30 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 9 papers in Immunology and 6 papers in Hematology. Recurrent topics in Smolen Js's work include Systemic Lupus Erythematosus Research (10 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and T-cell and B-cell Immunology (4 papers). Smolen Js is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and T-cell and B-cell Immunology (4 papers). Smolen Js collaborates with scholars based in Austria, United States and United Kingdom. Smolen Js's co-authors include Klaus Machold, van Riel Pl, Muirden Kd, Maarten Boers, Peter Tugwell, N. Khaltaev, John Kirwan, G Steiner, W. Hassfeld and O Scherak and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and PubMed.

In The Last Decade

Smolen Js

29 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Smolen Js Austria 11 458 183 165 101 65 30 654
Claudio Galarza-Maldonado Mexico 14 396 0.9× 177 1.0× 144 0.9× 71 0.7× 46 0.7× 24 594
R Fleischmann United States 8 375 0.8× 213 1.2× 187 1.1× 59 0.6× 90 1.4× 29 674
Gladman Dd Canada 14 661 1.4× 388 2.1× 192 1.2× 112 1.1× 40 0.6× 26 762
Laura Hunt United Kingdom 13 621 1.4× 137 0.7× 172 1.0× 54 0.5× 104 1.6× 42 874
C Dostál Czechia 14 347 0.8× 209 1.1× 59 0.4× 47 0.5× 56 0.9× 37 547
Д. Е. Каратеев Russia 11 436 1.0× 188 1.0× 147 0.9× 36 0.4× 56 0.9× 174 667
Arthur F. Kavanaugh United States 13 371 0.8× 377 2.1× 156 0.9× 36 0.4× 59 0.9× 20 689
Kristine Uramoto United States 7 703 1.5× 520 2.8× 185 1.1× 120 1.2× 37 0.6× 9 869
Daisuke Hoshi Japan 15 586 1.3× 112 0.6× 177 1.1× 150 1.5× 35 0.5× 53 792
Darcy S. Majka United States 10 463 1.0× 126 0.7× 94 0.6× 49 0.5× 58 0.9× 15 647

Countries citing papers authored by Smolen Js

Since Specialization
Citations

This map shows the geographic impact of Smolen Js's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smolen Js with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smolen Js more than expected).

Fields of papers citing papers by Smolen Js

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smolen Js. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smolen Js. The network helps show where Smolen Js may publish in the future.

Co-authorship network of co-authors of Smolen Js

This figure shows the co-authorship network connecting the top 25 collaborators of Smolen Js. A scholar is included among the top collaborators of Smolen Js based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smolen Js. Smolen Js is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saferding, Victoria, Melanie Hofmann, Antonia Puchner, et al.. (2018). O009 MIR-146A an important key player in bone metabolism. Annals of the Rheumatic Diseases. 77. A5–A5. 1 indexed citations
2.
Kavanaugh, Arthur, et al.. (2017). AB0235 Effect of baseline disease activity on achieving sustained low disease activity in baricitinib phase 3 studies. Annals of the Rheumatic Diseases. 76. 1130–1131. 1 indexed citations
3.
Pincus, Theodore, et al.. (2014). Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.. PubMed. 32(5 Suppl 85). S–1. 8 indexed citations
4.
Landewé, R., Edward Keystone, Smolen Js, et al.. (2011). DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH EARLY RA TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT METHOTREXATE ALONE: CASE FOR ANTI-TNF CARTILAGE PROTECTION. Lara D. Veeken. 50. 113–113. 2 indexed citations
5.
Dougados, Maxime, Greg D. Wells, N. Schmidely, et al.. (2010). Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data.. PubMed. 28(2). 258–60. 3 indexed citations
6.
Pincus, Theodore & Smolen Js. (2004). Early arthritis. Introduction.. PubMed. 21(5 Suppl 31). S1–S1. 2 indexed citations
7.
Stranzl, Thomas, et al.. (2003). Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis.. PubMed. 21(1). 27–32. 19 indexed citations
8.
Wick, Marius C., F. Kainberger, & Smolen Js. (2002). [Radiologic progression of rheumatoid arthritis in early basic drug therapy].. PubMed. 46–7. 1 indexed citations
9.
Erlacher, Ludwig, Judy Wyatt, Stephan Pflugbeil, et al.. (1998). Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.. PubMed. 16(1). 69–71. 10 indexed citations
10.
Boers, Maarten, Peter Tugwell, van Riel Pl, et al.. (1994). World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.. PubMed. 41. 86–9. 229 indexed citations
11.
Js, Smolen, W. Hassfeld, W. Graninger, & G Steiner. (1991). Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.. PubMed. 8 Suppl 5. 41–4. 6 indexed citations
12.
Graninger, W. & Smolen Js. (1988). [The pathogenesis of systemic lupus erythematosus--data and considerations].. PubMed. 15(5). 150–4.
13.
Js, Smolen. (1984). [Lyme disease--another tick-borne disease in Austria].. PubMed. 96(22). 823–9. 2 indexed citations
14.
Ad, Steĭnberg, et al.. (1983). The magnitude of the autologous mixed lymphocyte reaction itself is regulated.. PubMed. 153–62. 3 indexed citations
15.
Js, Smolen, et al.. (1982). The human autologous mixed lymphocyte reaction. II. Analysis of activation and proliferation.. PubMed. 9(3). 185–92. 4 indexed citations
16.
Js, Smolen & Steĭnberg Ad. (1981). Systemic lupus erythematosus and pregnancy: clinical, immunological, and theoretical aspects.. PubMed. 70. 283–302. 10 indexed citations
17.
Scherak, O, et al.. (1980). Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.. PubMed. 7(1). 9–12. 37 indexed citations
18.
Zielinski, Christoph, E. J. Menzel, Smolen Js, et al.. (1978). Leucocyte migration inhibition with collagen type I and collagen type III in rheumatoid arthritis and degenerative joint diseases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(3-4). 87–92. 18 indexed citations
19.
Js, Smolen, et al.. (1978). [Degradation of C1q, the first subcomponent of the complement sequence, by synovial collagenase from patients with rheumatoid arthritis (author's transl)].. PubMed. 90(20). 727–30. 2 indexed citations
20.
Js, Smolen, et al.. (1978). [Detection of collagenase in passive haemagglutination using collagen-coated erythrocytes (author's transl)].. PubMed. 90(20). 733–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Galarza-Maldonado Breakdown of academic impact, for papers by R Fleischmann Breakdown of academic impact, for papers by Gladman Dd Breakdown of academic impact, for papers by Laura Hunt Breakdown of academic impact, for papers by C Dostál Breakdown of academic impact, for papers by Д. Е. Каратеев Breakdown of academic impact, for papers by Arthur F. Kavanaugh Breakdown of academic impact, for papers by Kristine Uramoto Breakdown of academic impact, for papers by Daisuke Hoshi Breakdown of academic impact, for papers by Darcy S. Majka
Rankless by CCL
2026